FDA Home Page |
CFSAN Home | Search/Subject Index |
Q & A | Help
August 10, 2006
Final Report and Executive Summaries from the
AOAC International Presidential Task Force on
Best Practices in Microbiological Methodology
TABLE OF CONTENTS
(Full Document in PDF, 3.6MB)
- BPMM Task Force Final Report (available in PDF)
- Appendices
- Detection Limits WG Report (available in PDF)
- Matrix Extension WG Report (available in PDF)
- Matrix Extension Essential Organisms List (available in PDF)
- Sampling WG Executive Summary (available in PDF)
- Sampling WG Introduction (available in PDF)
- Sampling WG Enclosure A - Measurement Error (available in PDF)
- Sampling WG Enclosure B - Statistical Process Control (available in PDF)
- Appendices for Statistical Process Control (available in PDF, 1.7MB)
- Statistics WG Executive Summary (available in PDF)
- Statistics WG Report Part 1 - Developing Standards and Validating Performance (available in PDF)
- Statistics WG Report Part 2 - Study Variables (available in PDF)
- Statistics WG Report Part 3 - Uncertainty (available in PDF, 549KB)
- Statistics WG Report Part 4a - LOD 50 (available in PDF)
- Statistics WG Report Part 4b - LOD 50 Spearmann-Karber Worksheet (available in PDF)
- Classification Matrix (available in PDF)
- Recommendations for Future Research (available in PDF)
- Glossary (available in PDF)
- Task Force Membership (available in PDF)
- Steering Committe
- Detection Limits Working Group
- Matrix Extension Working Group
- Sampling Working Group
- Statistics Working Group
- AOAC Staff
Contract deliverable due to the U.S. Food and Drug Administration
August 10, 2006
Contract# 223-01-2464
Modification #12
Final Report and Executive Summaries from the AOAC International
Presidential Task Force on Best Practices in Microbiological Methodology